The Venture Codex Logo

The Venture Codex

Overview

Venture capital firm investing in early-stage technology and healthcare.

Founded

2010

Deals · 12mo

3

Stage focus

Series A
Series B

Geographic focus

Germany
Switzerland
The Netherlands
United Kingdom
...

Sector focus

Biotechnology
Finance
Venture Capital

Investment portfolio

71rounds
NAMEDATESIZE
Quantum Motion
May 2026Participated
$160 MSeries C
Silverflow
Mar 2026Participated
$40 MSeries B
TargED Biopharmaceuticals
Dec 2025Participated
$25 MSeries A
Salvia BioElectronics
May 2025Participated
$60 MSeries B
Draupnir Bio
Jul 2024Participated
$13 MSeed
iOnctura
Jun 2024Participated
$86 MSeries B
Provable Markets
May 2024Participated
$8 MSeries A
Onward
Mar 2024Participated
$22 MOther Equity
EclecticIQ
Mar 2024Participated
$3 MOther Equity
NMD Pharma
Nov 2023Participated
$81 MSeries B
Silverflow
Nov 2023Participated
$16 MOther Equity
VarmX
May 2023Participated
$32 MSeries B
Quantum Motion
May 2026Participated
$160 MSeries C
Silverflow
Mar 2026Participated
$40 MSeries B
TargED Biopharmaceuticals
Dec 2025Participated
$25 MSeries A
Salvia BioElectronics
May 2025Participated
$60 MSeries B
Draupnir Bio
Jul 2024Participated
$13 MSeed
iOnctura
Jun 2024Participated
$86 MSeries B
Provable Markets
May 2024Participated
$8 MSeries A
Onward
Mar 2024Participated
$22 MOther Equity
EclecticIQ
Mar 2024Participated
$3 MOther Equity
NMD Pharma
Nov 2023Participated
$81 MSeries B
Silverflow
Nov 2023Participated
$16 MOther Equity
VarmX
May 2023Participated
$32 MSeries B
71
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

INKEF Capital: 71 funding rounds are recorded in the selected participation categories.All available history.
INKEF Capital: 71 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed35
Series A1910
Series B813
Series C+13
Other Equity18

Monthly Deal Activity

INKEF Capital: 71 deals are recorded across 186 months.All available history.
INKEF Capital: 71 deals are recorded across 186 months. All available history
MonthDeals
May '111
Jun '111
Jul '110
Aug '110
Sep '110
Oct '110
Nov '110
Dec '110
Jan '120
Feb '120
Mar '120
Apr '120
May '120
Jun '120
Jul '120
Aug '120
Sep '120
Oct '120
Nov '121
Dec '120
Jan '130
Feb '131
Mar '130
Apr '130
May '130
Jun '130
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '140
Aug '140
Sep '140
Oct '140
Nov '140
Dec '140
Jan '151
Feb '150
Mar '150
Apr '150
May '150
Jun '151
Jul '150
Aug '150
Sep '151
Oct '150
Nov '150
Dec '151
Jan '161
Feb '161
Mar '160
Apr '161
May '160
Jun '160
Jul '161
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '171
Mar '170
Apr '170
May '170
Jun '170
Jul '171
Aug '170
Sep '170
Oct '171
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '181
Jun '180
Jul '181
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '192
Feb '192
Mar '191
Apr '190
May '190
Jun '191
Jul '190
Aug '190
Sep '190
Oct '191
Nov '190
Dec '190
Jan '201
Feb '200
Mar '200
Apr '201
May '203
Jun '200
Jul '203
Aug '201
Sep '201
Oct '201
Nov '200
Dec '201
Jan '211
Feb '211
Mar '210
Apr '213
May '210
Jun '212
Jul '211
Aug '211
Sep '211
Oct '210
Nov '210
Dec '212
Jan '221
Feb '222
Mar '223
Apr '220
May '220
Jun '220
Jul '222
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '231
Mar '231
Apr '230
May '232
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '232
Dec '230
Jan '240
Feb '240
Mar '242
Apr '240
May '241
Jun '241
Jul '241
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '261
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

INKEF Capital: Health & Life Sciences is the largest displayed sector by deal count (38 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

INKEF Capital: Health & Life Sciences is the largest displayed sector by deal count (38 deals). All available history
SectorDeals
Health & Life Sciences38
Enterprise Software15
AI & Machine Learning12
Fintech8
Networks, Cloud & Communication7
Social & Community Platforms7
E-Commerce & Retail6
Consumer & Lifestyle6
Professional Services6
Space & Frontier Tech5
Manufacturing5
Travel & Hospitality3
Real Estate & Construction3
Hardware & Robotics3
Cybersecurity & Privacy2
Marketing & Advertising2
Media & Entertainment2
Government & Defense1
Data, Analytics & IT1
Developer Tools1

Deal Size Distribution

INKEF Capital: 71 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

INKEF Capital: 71 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M8
$5M-$10M15
$10M-$25M18
$25M-$50M17
$50M-$100M12
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

INKEF Capital: Europe has the largest recorded deal count among the displayed regions (61 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

INKEF Capital: Europe has the largest recorded deal count among the displayed regions (61 deals). All available history
RegionDeals
Europe61
United States9
Canada1
INKEF Capital: 20 co-investors are shown, with EQT Life Sciences (LSP) sharing 11 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

INKEF Capital: Led accounts for 45% and participating for 55% of round participation.All available history.
INKEF Capital: Led accounts for 45% and participating for 55% of round participation. All available history
CategoryDeals (count)Share (%)
Led3245%
Participating3955%
INKEF Capital: Single-lead accounts for 53% and co-led for 47% of lead dynamics.All available history.
INKEF Capital: Single-lead accounts for 53% and co-led for 47% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1753%
Co-led1547%

Team

Ivan Burkov

Principal

Janneke van Dongen

Executive Assistant

Lisa Diepgrond

Executive Assistant

Mirella Tempelaars

Office Manager